Ionis Pharmaceuticals Inc
NASDAQ:IONS
Income Statement
Earnings Waterfall
Ionis Pharmaceuticals Inc
Revenue
|
787.6m
USD
|
Cost of Revenue
|
-9.1m
USD
|
Gross Profit
|
778.5m
USD
|
Operating Expenses
|
-1.1B
USD
|
Operating Income
|
-353.7m
USD
|
Other Expenses
|
-12.6m
USD
|
Net Income
|
-366.3m
USD
|
Income Statement
Ionis Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
147
N/A
|
132
-10%
|
151
+14%
|
172
+14%
|
214
+25%
|
249
+16%
|
312
+25%
|
317
+2%
|
284
-11%
|
258
-9%
|
176
-32%
|
238
+35%
|
373
+57%
|
426
+14%
|
499
+17%
|
507
+1%
|
514
+1%
|
543
+6%
|
548
+1%
|
575
+5%
|
600
+4%
|
752
+25%
|
799
+6%
|
821
+3%
|
1 123
+37%
|
959
-15%
|
941
-2%
|
933
-1%
|
729
-22%
|
708
-3%
|
688
-3%
|
661
-4%
|
811
+23%
|
841
+4%
|
849
+1%
|
876
+3%
|
587
-33%
|
576
-2%
|
631
+9%
|
615
-2%
|
788
+28%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(3)
|
(4)
|
(5)
|
(4)
|
(6)
|
(8)
|
(10)
|
(12)
|
(12)
|
(12)
|
(12)
|
(11)
|
(13)
|
(14)
|
(13)
|
(14)
|
(11)
|
(9)
|
(10)
|
(9)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
373
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
514
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
598
N/A
|
487
-19%
|
649
+33%
|
816
+26%
|
1 118
+37%
|
953
-15%
|
933
-2%
|
923
-1%
|
717
-22%
|
696
-3%
|
676
-3%
|
649
-4%
|
800
+23%
|
828
+4%
|
835
+1%
|
863
+3%
|
573
-34%
|
565
-2%
|
622
+10%
|
605
-3%
|
779
+29%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(199)
|
(215)
|
(233)
|
(249)
|
(262)
|
(284)
|
(296)
|
(328)
|
(360)
|
(379)
|
(391)
|
(388)
|
(393)
|
(402)
|
(420)
|
(428)
|
(483)
|
(542)
|
(604)
|
(654)
|
(659)
|
(686)
|
(699)
|
(700)
|
(752)
|
(836)
|
(783)
|
(812)
|
(859)
|
(898)
|
(900)
|
(922)
|
(806)
|
(833)
|
(843)
|
(844)
|
(984)
|
(1 032)
|
(1 093)
|
(1 161)
|
(1 132)
|
|
Selling, General & Administrative |
(15)
|
(16)
|
(17)
|
(18)
|
(20)
|
(23)
|
(27)
|
(31)
|
(37)
|
(40)
|
(42)
|
(44)
|
(49)
|
(52)
|
(64)
|
(81)
|
(109)
|
(139)
|
(182)
|
(224)
|
(245)
|
(269)
|
(278)
|
(269)
|
(287)
|
(293)
|
(290)
|
(299)
|
(332)
|
(341)
|
(325)
|
(288)
|
(171)
|
(159)
|
(137)
|
(140)
|
(150)
|
(162)
|
(174)
|
(210)
|
(233)
|
|
Research & Development |
(184)
|
(199)
|
(216)
|
(231)
|
(242)
|
(253)
|
(262)
|
(289)
|
(322)
|
(339)
|
(348)
|
(345)
|
(344)
|
(346)
|
(352)
|
(348)
|
(375)
|
(396)
|
(414)
|
(430)
|
(415)
|
(417)
|
(421)
|
(431)
|
(466)
|
(476)
|
(492)
|
(513)
|
(527)
|
(558)
|
(575)
|
(635)
|
(635)
|
(665)
|
(706)
|
(705)
|
(833)
|
(870)
|
(919)
|
(951)
|
(900)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(8)
|
(8)
|
(8)
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
0
|
0
|
(8)
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
(66)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(52)
N/A
|
(83)
-61%
|
(82)
+1%
|
(78)
+5%
|
(48)
+39%
|
(36)
+25%
|
16
N/A
|
(11)
N/A
|
(76)
-589%
|
(121)
-60%
|
(215)
-77%
|
(150)
+30%
|
(20)
+87%
|
24
N/A
|
79
+232%
|
79
-1%
|
31
-60%
|
1
-98%
|
(56)
N/A
|
(78)
-40%
|
(61)
+22%
|
63
N/A
|
95
+50%
|
116
+22%
|
366
+215%
|
117
-68%
|
150
+28%
|
111
-26%
|
(142)
N/A
|
(203)
-43%
|
(224)
-10%
|
(274)
-22%
|
(6)
+98%
|
(4)
+32%
|
(8)
-91%
|
18
N/A
|
(410)
N/A
|
(467)
-14%
|
(472)
-1%
|
(556)
-18%
|
(354)
+36%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(15)
|
(16)
|
(17)
|
(16)
|
2
|
(3)
|
(6)
|
10
|
(12)
|
(12)
|
(12)
|
(33)
|
(33)
|
(35)
|
(36)
|
(35)
|
(37)
|
(35)
|
(31)
|
(25)
|
(15)
|
(7)
|
1
|
4
|
40
|
48
|
62
|
66
|
38
|
32
|
16
|
14
|
11
|
2
|
(5)
|
1
|
10
|
33
|
57
|
67
|
74
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
(12)
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(66)
|
0
|
(66)
|
(66)
|
(30)
|
0
|
(9)
|
(9)
|
(33)
|
0
|
0
|
0
|
0
|
0
|
11
|
9
|
13
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
150
|
0
|
0
|
0
|
(0)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(3)
|
(4)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(13)
|
(8)
|
(7)
|
128
|
122
|
104
|
(68)
|
|
Pre-Tax Income |
(67)
N/A
|
(99)
-48%
|
(98)
+0%
|
(94)
+5%
|
(54)
+42%
|
(38)
+29%
|
9
N/A
|
(1)
N/A
|
(88)
-6 662%
|
(133)
-52%
|
(227)
-70%
|
(184)
+19%
|
(58)
+69%
|
(12)
+79%
|
42
N/A
|
28
-33%
|
(17)
N/A
|
(37)
-117%
|
(90)
-146%
|
(103)
-15%
|
(76)
+26%
|
57
N/A
|
96
+69%
|
119
+24%
|
339
+184%
|
164
-52%
|
145
-11%
|
110
-24%
|
(135)
N/A
|
(171)
-27%
|
(216)
-26%
|
(269)
-24%
|
(29)
+89%
|
(4)
+88%
|
(26)
-640%
|
11
N/A
|
(258)
N/A
|
(307)
-19%
|
(281)
+8%
|
(375)
-33%
|
(334)
+11%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
6
|
8
|
6
|
(1)
|
15
|
14
|
14
|
15
|
(0)
|
(1)
|
(0)
|
(0)
|
(3)
|
(3)
|
(3)
|
(4)
|
113
|
113
|
113
|
114
|
(41)
|
(72)
|
(65)
|
(49)
|
(52)
|
(17)
|
(26)
|
(46)
|
(345)
|
(348)
|
(347)
|
(340)
|
1
|
(0)
|
(2)
|
(4)
|
(12)
|
(22)
|
(28)
|
(34)
|
(32)
|
|
Income from Continuing Operations |
(61)
|
(90)
|
(92)
|
(94)
|
(39)
|
(24)
|
23
|
14
|
(88)
|
(135)
|
(227)
|
(184)
|
(60)
|
(15)
|
39
|
24
|
97
|
77
|
23
|
10
|
(117)
|
(16)
|
31
|
70
|
287
|
147
|
119
|
64
|
(480)
|
(520)
|
(563)
|
(609)
|
(29)
|
(4)
|
(28)
|
7
|
(270)
|
(329)
|
(309)
|
(409)
|
(366)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
11
|
21
|
37
|
48
|
59
|
43
|
36
|
28
|
(9)
|
8
|
10
|
15
|
36
|
25
|
13
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(61)
N/A
|
(90)
-49%
|
(92)
-2%
|
(94)
-2%
|
(39)
+59%
|
(24)
+37%
|
23
N/A
|
14
-39%
|
(88)
N/A
|
(135)
-52%
|
(227)
-69%
|
(184)
+19%
|
(60)
+67%
|
(15)
+76%
|
39
N/A
|
29
-26%
|
0
-99%
|
(10)
N/A
|
(47)
-373%
|
(49)
-4%
|
274
N/A
|
360
+31%
|
399
+11%
|
430
+8%
|
278
-35%
|
154
-45%
|
129
-16%
|
79
-39%
|
(444)
N/A
|
(495)
-11%
|
(550)
-11%
|
(608)
-11%
|
(29)
+95%
|
(4)
+86%
|
(28)
-605%
|
7
N/A
|
(270)
N/A
|
(329)
-22%
|
(309)
+6%
|
(409)
-32%
|
(366)
+11%
|
|
EPS (Diluted) |
-0.53
N/A
|
-0.78
-47%
|
-0.79
-1%
|
-0.81
-3%
|
-0.33
+59%
|
-0.21
+36%
|
0.18
N/A
|
0.11
-39%
|
-0.74
N/A
|
-1.12
-51%
|
-1.88
-68%
|
-1.48
+21%
|
-0.5
+66%
|
-0.13
+74%
|
0.32
N/A
|
0.24
-25%
|
0
N/A
|
-0.07
N/A
|
-0.36
-414%
|
-0.34
+6%
|
2.04
N/A
|
2.54
+25%
|
2.84
+12%
|
2.99
+5%
|
1.82
-39%
|
1.1
-40%
|
0.92
-16%
|
0.56
-39%
|
-3.18
N/A
|
-3.53
-11%
|
-3.89
-10%
|
-4.32
-11%
|
-0.2
+95%
|
-0.02
+90%
|
-0.19
-850%
|
0.06
N/A
|
-1.9
N/A
|
-2.31
-22%
|
-2.17
+6%
|
-2.87
-32%
|
-2.56
+11%
|